|
![](https://webarchive.library.unt.edu/eot2008/20090201151835im_/http://www.nida.nih.gov/images/spacer.gif)
Office of the Director
Wilson M. Compton, M.D., M.P.E.
Director
(301) 443-6504
Dr. Compton is the Director of the Division of Epidemiology, Services and Prevention Research at the National Institute on Drug Abuse (NIDA). Prior to joining NIDA, Dr. Compton was Associate Professor of Psychiatry and Director of the Master in Psychiatric Epidemiology Program at Washington University in Saint Louis as well as Medical Director of Addiction Services at the Barnes-Jewish Hospital in Saint Louis. Dr. Compton received his undergraduate education from Amherst College. He attended medical school and completed his residency training in psychiatry at Washington University. He is a member of the Alpha Omega Alpha honor society as well as numerous professional organizations. He has been the principal or co-principal of multiple federally funded grants focusing on the epidemiology of drug abuse, HIV prevention and co-occurring mental and drug use disorders. In these areas of research, Dr. Compton has authored over 90 articles and chapters, and several diagnostic interviews.
Kevin P. Conway, Ph.D.
Deputy Director
(301) 443-6504
Dr. Conway is the Deputy Director of the Division of Epidemiology, Services and Prevention Research at the National Institute on Drug Abuse (NIDA). Before assuming this position in 2007, he served as Associate Director of the Division of Clinical Neuroscience and Behavioral Research at NIDA, and Deputy Branch Chief and Program Director for the Epidemiology Research Branch at NIDA. Prior to joining NIDA in 2001, Dr. Conway was an Associate Research Scientist in the Genetic Epidemiology Research Unit in the Department of Epidemiology and Public Health at the Yale University School of Medicine. Dr. Conway earned the Ph.D. in Experimental Psychology from Temple University in 1998. Dr. Conway has authored numerous peer-reviewed articles and book chapters focusing on the epidemiology of drug abuse, co-occurring psychiatric disorders, and violence.
Meyer D. Glantz, Ph.D.
Associate Director for Science
(301) 402-1503
Dr. Glantz is currently the Associate Director for Science of the Division of Epidemiology and Prevention Research (DESPR) of the National Institute on Drug Abuse, National Institutes of Health and the Chief of the Analytic Unit. At NIDA, Dr. Glantz has previously served as the Acting Deputy Director of DESPR and the Chief of the Epidemiology Research Branch and the Director of the Etiology Research Program. Prior to coming to NIDA he worked as a researcher and clinician at the Veterans Administration Clinic in Boston. Dr. Glantz is a Fellow of the American Psychological Association and serves as a consultant to and board member of a variety of scientific and professional organizations and publications. He is the author of numerous articles and chapters on substance abuse, drug abuse etiology, cognitive therapy, prevention, and the elderly and has edited several volumes including Vulnerability to Drug Abuse, Biobehavioral Research Approaches to Drug Abuse Etiology, Resilience and Development: Positive Life Adaptations, and Drug Abuse: Origins and Interventions. In addition, he maintains a private clinical practice in the Washington D.C. area, supervises other clinicians, is a lecturer for the Montgomery County Adult Education program and has taught at several area universities. Dr. Glantz received his doctorate from Harvard University in 1979.
Marc D. Brodsky, M.Sc.
Statistician
(301) 402-1849
Mr. Brodsky is a statistician with the DESPRs Analytic Unit. Trained in Sociology at the University of Rochester, and Quality Control Statistics at the Rochester Institute of Technology. Mr. Brodsky also has experience in Operations Research for the Department of the Army and the NIMH prior to coming to NIDA. He also holds a degree in Electrical Engineering Technology. In his career at NIDA, Mr. Brodsky has been involved with a number of analyses, including development of estimates of the incidence of initial drug use based on retrospective reports.
Division of Epidemiology, Services and Prevention Research
Office of the Director
National Institute on Drug Abuse
6001 Executive Boulevard
Room 5153, MSC 9589
Bethesda, Maryland 20892-9589
Phone: (301) 443-6504
Fax: (301) 443-2636
|
|
|